Tag: Liver Disease: Misc.
Lanifibranor Reduces Disease Activity in Nonalcoholic Steatohepatitis
In phase 2b trial, more patients with active NASH had reduction in disease activity score with lanifibranor versus placebo
Survival Rates Lower for Black Liver Transplant Recipients
For Blacks versus Whites, differences in post-LT mortality narrowed between 2002 and 2009, increased between 2014 and 2018
Donor HLA Evolutionary Divergence May Predict Liver Transplant Rejection
Class I HED of the donor is associated with higher risk for acute and chronic rejection of the liver transplant
Toxic Dust Exposure Tied to Liver Disease in WTC Responders
Earlier arrival time at World Trade Center associated with decreased liver attenuation on computed tomography
Maternal Obesity May Up Risk for Future Liver Disease in Offspring
Maternal obesity in early pregnancy linked to increased risk for nonalcoholic fatty liver disease in the child by age 25 years
Better Strategies Needed for Managing NAFLD in Adults
Needs assessment survey conducted in response to increasing clinical burden of nonalcoholic fatty liver disease, nonalcoholic steatohepatitis
Hepatitis B Virus Monitoring Needed After Liver Transplantation
While the risk is small, there have been 20 cases of unexpected donor-derived hepatitis B virus infection
All Types of Coffee May Protect Against Chronic Liver Disease
Lower risk for chronic liver disease and related outcomes seen for consumption of brewed decaffeinated, instant, and ground coffee
DDW: Alcohol-Related GI, Liver Diseases Up During Pandemic
Demand increased for inpatient consults, inpatient endoscopic interventions for alcohol-related GI, liver diseases, particularly alcoholic hepatitis
Risk Factors for Drug-Induced Liver Injury ID’d in Hospitalized Patients
Risk for DILI up for patients with hyperlipidemia, cardiovascular disease, preexisting liver disease, surgical history